My Application Form Status

Check the status of your application form with Angel Broking.
Volumes jump at Shoppers Stop counter
Nov 22,2016

Shoppers Stop clocked volume of 3.42 lakh shares by 13:43 IST on BSE, a 586.92-times surge over two-week average daily volume of 1,000 shares. The stock rose 1.44% to Rs 298.60.

Wim Plast notched up volume of 12.24 lakh shares, a 258.90-fold surge over two-week average daily volume of 5,000 shares. The stock rose 1.3% to Rs 1,415. A large bulk deal of 12.01 lakh shares was executed on the scrip at Rs 1,370 per share in early trade on BSE.

UPL saw volume of 6.22 lakh shares, a 6.67-fold surge over two-week average daily volume of 93,000 shares. The stock dropped 2.71% to Rs 591.50.

Kotak Mahindra Bank clocked volume of 5.49 lakh shares, a 2.75-fold surge over two-week average daily volume of 2 lakh shares. The stock rose 0.23% to Rs 764.25.

Castrol India saw volume of 2.27 lakh shares, a 1.92-fold rise over two-week average daily volume of 1.18 lakh shares. The stock rose 0.3% to Rs 386.

Powered by Capital Market - Live News

Bliss GVS Pharma sweetens after overseas order win
Nov 22,2016

The announcement was made during market hours today, 22 November 2016.

Meanwhile, the S&P BSE Sensex was up 58.85 points or 0.23% at 25,823.99

On BSE, so far 1.05 lakh shares were traded in the counter as against average daily volume of 1.03 lakh shares in the past one quarter. The stock hit a high of Rs 125.80 and a low of Rs 117.50 so far during the day. The stock had hit a 52-week high of Rs 201.30 on 27 November 2015. The stock had hit a 52-week low of Rs 79 on 17 June 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, sliding 24.03% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, declining 11.12% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 10.31 crore. Face value per share is Re 1.

Bliss GVS Healthcare, the Kenyan step down subsidiary of Bliss GVS Pharma, has won a three year contract worth $111.40 million from Aon Kenya Insurance Brokers, for provision of Medical Healthcare Services in Kenya. This contract covers outpatient services for over 3.04 lakh members. This medical cover is to be managed by Aon Kenya Insurance Brokers will benefit the principle contributor, his/her spouse and up to four children, the company said.

Bliss GVS Pharma said the medical cover provides for dental, optical on an out-patient basis and for maternity. The service payments will be received by the company from Aon, in advance, on a quarterly basis, the company said. Part payment for the first quarter payment has been received by the company, it added.

Bliss GVS Pharmas consolidated net profit fell 40.76% to Rs 13.65 crore on 6.72% decline in total income to Rs 171.35 crore in Q2 September 2016 over Q2 September 2015.

Bliss GVS Pharma is a fast-growing pharmaceutical company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.

Powered by Capital Market - Live News

RattanIndia Infra slips after Morgan Stanley pares stake
Nov 22,2016

Meanwhile, the BSE Sensex was up 34.86 points, or 0.14%, to 25,800.

On BSE, so far 85,000 shares were traded in the counter, compared with average daily volume of 4.49 lakh shares in the past one quarter. The stock hit a high of Rs 2.99 and a low of Rs 2.85 so far during the day. The stock hit a 52-week high of Rs 4.34 on 12 May 2016. The stock hit a 52-week low of Rs 2.85 on 22 November 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 8.84% compared with the 8.23% decline in the Sensex. The scrip had also underperformed the market in past one quarter, sliding 16.25% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 276.45 crore. Face value per share is Rs 2.

As on 30 September 2016, Morgan Stanley Asia (Singapore) held 2.24 crore shares, or 1.626% stake, of RattanIndia Infrastructure.

RattanIndia Infrastructure reported net loss of Rs 1.64 crore in Q1 June 2016 as against net loss of Rs 0.12 crore in Q1 June 2015. There were no sales reported in Q1 June 2016 and in Q1 June 2015.

Powered by Capital Market - Live News

Wim Plast advances after large bulk deal
Nov 22,2016

Meanwhile, the S&P BSE Sensex was up 56.05 points, or 0.22%, to 25,821.19

Bulk deal boosted volume on the scrip. On BSE, so far 12.23 lakh shares were traded in the counter, compared with average daily volume of 3,964 shares in the past one quarter. The stock hit a high of Rs 1,540 and a low of Rs 1,320 so far during the day. The stock hit a record high of Rs 1,660 on 8 November 2016. The stock hit a 52-week low of Rs 775.50 on 1 April 2016. The stock had outperformed the market over the past 30 days till 21 November 2016, falling 4.39% compared with the 8.23% decline in the Sensex. The scrip also outperformed the market in past one quarter, gaining 12% as against Sensexs 7.95% decline.

The small-cap company has an equity capital of Rs 12 crore. Face value per share is Rs 10.

Wim Plasts consolidated net profit rose 5.18% to Rs 9.13 crore on 4.88% fall in total income to Rs 77.69 crore in Q2 September 2016 over Q2 September 2015.

Wim Plast manufactures plastic moulded furnitures.

Powered by Capital Market - Live News

L&T slips ahead of Q2 results
Nov 22,2016

Meanwhile, the BSE Sensex was up 48.21 points, or 0.19%, to 25,813.35.

On BSE, so far 1.05 lakh shares were traded in the counter, compared with average daily volume of 2.55 lakh shares in the past one quarter. The stock hit a high of Rs 1,360 and a low of Rs 1,306.60 so far during the day. The stock hit a 52-week high of Rs 1,615 on 27 July 2016. The stock hit a 52-week low of Rs 1,016.60 on 12 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, sliding 10.74% compared with the 8.23% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 8.63% as against Sensexs 7.95% decline.

The large-cap company has equity capital of Rs 186.47 crore. Face value per share is Rs 2.

L&T announced during trading hours today, 22 November 2016, that its construction arm has won orders worth Rs 1926 crore across its various business segments.

L&Ts consolidated net profit rose 45.5% to Rs 609.60 crore on 9.3% growth in net sales to Rs 21718.61 crore in Q1 June 2016 over Q1 June 2015.

L&T is a major Indian multinational engaged in technology, engineering, construction, manufacturing and financial services. It operates in more than 30 countries worldwide.

Powered by Capital Market - Live News

Sobha hits 52-week low after poor Q2 result
Nov 22,2016

The result was announced after market hours yesterday, 21 November 2016.

Meanwhile, the BSE Sensex was up 80.09 points, or 0.31%, to 25,845.23

On BSE, so far 9,547 shares were traded in the counter, compared with average daily volume of 13,180 shares in the past one quarter. The stock hit a high of Rs 234.05 so far during the day. The stock hit a low of Rs 224.05 in intraday trade so far, which is 52-week low for the counter. The stock hit a 52-week high of Rs 346 on 26 July 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 18.44% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, sliding 18.25% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 98.06 crore. Face value per share is Rs 10.

In Q2 September 2016, Sobha achieved new sales of 8.55 lakh square feet, valued at Rs 551 crore with an average realisation of Rs 6443 per square feet (Sobhas share of sale value stood at Rs 518 crore with an average realisation of Rs 6056 per square feet).

J.C. Sharma, Vice Chairman and Managing Director, Sobha said that the company has seen consistent improvement in cash flow and generated net positive operational cash flow for the past five consecutive quarters.

Sobha is a backward integrated real estate player. The company is primarily focused on residential and contractual projects.

Powered by Capital Market - Live News

Panacea Biotec gains over 3% in two sessions
Nov 22,2016

The announcement was made during market hours yesterday, 21 November 2016. Shares of Panacea Biotec rose 2.32% to Rs 107.95 on that day. The stock has risen 3.32% in two trading sessions from its close of Rs 105.50 on 18 November 2016.

Meanwhile, the BSE Sensex was up 100.04 points, or 0.39%, to 25,865.18.

On BSE, so far 2,493 shares were traded in the counter, compared with average daily volume of 14,290 shares in the past one quarter. The stock hit a high of Rs 111.85 and a low of Rs 108.60 so far during the day. The stock hit a 52-week high of Rs 171.20 on 4 December 2015. The stock hit a 52-week low of Rs 83.90 on 12 February 2016. The stock had outperformed the market over the past 30 days till 21 November 2016, rising 0.47% compared with the 8.23% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 1.51% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 6.13 crore. Face value per share is Rs 1.

Panacea Biotec has state-of-the-art pharmaceutical formulation facility located at Baddi for oral solids and oncology parenteral formulations. The company has been supplying products in US markets for approved abbreviated new drug applications (ANDAs) manufactured in oral solids dosage facility. A number of ANDAs submitted by the company, referring these facilities, are also at various stages of approval by the United States Food and Drug Administration (USFDA).

Panacea Biotec reported net loss of Rs 11.84 crore in Q2 September 2016, lower than net loss of Rs 17 crore in Q2 September 2015. Net sales declined 18.3% to Rs 131.56 crore in Q2 September 2016 over Q2 September 2015.

Panacea Biotec is one of Indias leading research based health management companies with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers in India and is one of the leading biotechnology companies.

Powered by Capital Market - Live News

Vedanta firms up ahead of board meeting
Nov 22,2016

Meanwhile, the BSE Sensex was up 119.70 points, or 0.46%, to 25,884.84.

On BSE, so far 4.06 lakh shares were traded in the counter, compared with average daily volume of 11.33 lakh shares in the past one quarter. The stock hit a high of Rs 204.85 and a low of Rs 199.10 so far during the day. The stock hit a 52-week high of Rs 233.65 on 10 November 2016. The stock hit a 52-week low of Rs 58.10 on 12 February 2016. The stock had outperformed the market over the past 30 days till 21 November 2016, falling 3.10% compared with the 8.23% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 13.15% as against Sensexs 7.95% decline.

The large-cap company has equity capital of Rs 296.47 crore. Face value per share is Re 1.

On a consolidated basis, Vedantas net profit rose 17.14% to Rs 1252.13 crore on 4.13% decline in net sales to Rs 15665.64 crore in Q2 September 2016 over Q2 September 2015.

Vedanta is a diversified natural resources company, whose business primarily involves producing oil & gas, zinc - lead - silver, copper, iron ore, aluminium and commercial power. The company has a presence across India, South Africa, Namibia, Australia and Ireland.

Powered by Capital Market - Live News

Suven Life Sciences in pink of health after securing two product patents
Nov 22,2016

The announcement was made during trading hours today, 22 November 2016.

Meanwhile, the BSE Sensex was up 99.64 points, or 0.39%, to 25,864.78

On BSE, so far 13,000 shares were traded in the counter, compared with average daily volume of 70,299 shares in the past one quarter. The stock hit a high of Rs 170 and a low of Rs 165.50 so far during the day. The stock hit a 52-week high of Rs 275.20 on 29 December 2015. The stock hit a 52-week low of Rs 144.35 on 19 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 16.28% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, sliding 16.32% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 12.73 crore. Face value per share is Re 1.

Suven Life Sciences announced the grant of one product patent from China and one product patent from Mexico corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2032 and 2031 respectively. The granted claims of the patents are from the mechanism of action include the class of selective H3 inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimers disease, Attention deficient hyperactivity disorder (ADHD), Huntingtons disease, Major Depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, Suven Life Sciences said that the company has a total of twenty one granted patents from China and twenty two granted patents from Mexico. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts, the company said. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II, it added.

Suven Life Sciences net profit rose 58.2% to Rs 32.58 crore on 31.7% rise in net sales to Rs 133.23 crore in Q1 June 2016 over Q1 June 2015.

Suven Life Sciences is a biopharmaceutical company specializing in drug discovery and developmental activities in central nervous system disorders and contract research and manufacturing services (CRAMS).

Powered by Capital Market - Live News

Asian Oilfield Services jumps after winning contracts from Oil India
Nov 22,2016

The announcement was made after market hours yesterday, 21 November 2016.

Meanwhile, the BSE Sensex was up 178.26 points, or 0.69%, to 25,943.40.

On BSE, so far 72,000 shares were traded in the counter, compared with average daily volume of 97,910 shares in the past one quarter. The stock hit a 52-week high of Rs 89.80 on 25 October 2016. The stock hit a 52-week low of Rs 27.90 on 12 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 13.63% compared with the 8.23% decline in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 2.49% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 22.32 crore. Face value per share is Rs 10.

Asian Oilfield Services said it received letters of award of two contracts by Oil India for acquisition of 2D Seismic Data in unappraised on land areas of North East India for an estimated total value of Rs 140 crore for both the contracts.

On a consolidated basis, Asian Oilfield Services reported net loss of Rs 11.12 crore in Q2 September 2016 as against net profit of Rs 4.09 crore in Q2 September 2015. Net sales declined 94.72% to Rs 3.09 crore in Q2 September 2016 over Q2 September 2015.

Asian Oilfield Services is engaged in providing geophysical, drilling and well services to customers across the Indian sub-continent.

Powered by Capital Market - Live News

AXIS Bank gains on fund raising plan
Nov 22,2016

The announcement was made after market hours yesterday, 21 November 2016.

Meanwhile, the BSE Sensex was up 232.51 points, or 0.90%, to 25,997.65.

On BSE, so far 25,000 shares were traded in the counter, compared with average daily volume of 7.01 lakh shares in the past one quarter. The stock hit a high of Rs 471 and a low of Rs 467.90 so far during the day. The stock hit a 52-week high of Rs 638 on 7 September 2016. The stock hit a 52-week low of Rs 366.65 on 18 January 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 11.54% compared with the 8.23% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 20% as against Sensexs 7.95% decline.

The large-cap private sector bank has equity capital of Rs 478.17 crore. Face value per share is Rs 2.

AXIS Bank said it proposes to raise funds by issuing unsecured redeemable non-convertible subordinated debentures (Basel- III compliant Tier II debentures) (Series - 25) of the face value of Rs 10 lakh each for cash at par aggregating to Rs 1800 crore. The board of directors of the bank will consider the proposal to issue and allot the above securities through circular resolution.

Axis Banks net profit declined 83.3% to Rs 319.08 crore on 14.1% growth in operating income to Rs 13698.77 crore in Q2 September 2016 over Q2 September 2015.

Axis Bank is one of the biggest private sector banks in India.

Powered by Capital Market - Live News

G E Shipping sails smoothly after sale and delivery of support vessel
Nov 21,2016

The announcement was made after market hours on Friday, 18 November 2016.

Meanwhile, the BSE Sensex was down 362.42 points, or 1.39%, to 25,787.82

On BSE, so far 11,100 shares were traded in the counter, compared with an average volume of 30,482 shares in the past one quarter. The stock hit a high of Rs 363.40 and a low of Rs 351 so far during the day. The stock hit a 52-week high of Rs 400 on 19 November 2015. The stock hit a 52-week low of Rs 275 on 2 March 2016.

The mid-cap company has an equity capital of Rs 150.78 crore. Face value per share is Rs 10.

Great Eastern Shipping Company said that Greatship Global Offshore Services, a Singapore incorporated subsidiary of Greatship (India) (GIL), which is a wholly-owned subsidiary of the company, has sold and delivered its 2013.-built ROV Support Vessel (ROVSV) Greatship Ragini to the buyers. With the delivery of this vessel to the buyers, GIL and its subsidiaries currently own and operate five Platform Supply Vessels (PSVs), eight Anchor Handling Tug Supply Vessels (AHTSVs), two Multipurpose Platform Supply and Support Vessels (MPSSVs), five R-class supply vessels and four jack-up rigs, Great Eastern Shipping Company said.

On a consolidated basis, G E Shippings net profit fell 23.99% to Rs 268.75 crore on 21.12% decline in net sales to Rs 794.51 crore in Q2 September 2016 over Q2 September 2015.

G E Shipping has two main business: shipping and offshore. The shipping business is involved in transportation of crude oil, petroleum products, gas and dry bulk commodities. The offshore business services to the oil companies in carrying out offshore exploration and production activities, through its subsidiary Greatship (India).

Powered by Capital Market - Live News

Dr. Lal PathLabs hits record high
Nov 21,2016

The announcement was made during market hours today, 21 November 2016.

Meanwhile, the S&P BSE Sensex was down 389.78 points or 1.49% at 25,760.46.

On BSE, so far 33,000 shares were traded in the counter as against average daily volume of 11,000 shares in the past two weeks. The stock hit a high of Rs 1,278.55 so far during the day, which is a record high for the counter. The stock hit a low of Rs 1,175 so far during the day. The stock had hit a record low of Rs 696.50 on 20 January 2016.

Dr. Lal PathLabs said it expects to complete the acquisition of Delta Ria & Pathology (DRPPL) by 31 March 2017. The company had in May 2016, announced the acquisition of DRPPL.

Dr. Lal PathLabs consolidated net profit jumped 748.3% to Rs 52.51 crore on 21.52% growth in total income from operations to Rs 262.17 crore in Q2 September 2016 over Q2 September 2015.

Dr. Lal PathLabs is a provider of diagnostics and related healthcare tests and services in India. Customers include individual patients, companies and institutions, healthcare providers as well as hospital and clinical labs.

Powered by Capital Market - Live News

Shalimar Paints tumbles after intimating about fire at Nasik plant
Nov 21,2016

The announcement was made during market hours today, 21 November 2016.

Meanwhile, the S&P BSE Sensex was down 359.83 points or 1.38% at 25,790.41

On BSE, so far 24,250 shares were traded in the counter as against average daily volume of 56,436 shares in the past one quarter. The stock hit a high of Rs 140 and a low of Rs 123.40 so far during the day. The stock hit a record high of Rs 223.60 on 23 August 2016. The stock hit a 52-week low of Rs 88.70 on 12 February 2016.

The small-cap company has equity capital of Rs 3.79 crore. Face value per share is Rs 2.

Shalimar Paints said that there has been no loss or injury to human life. The company is in the process of ascertaining the actual loss caused by the fire and also is in process of informing the same to the insurance company, Shalimar Paints said. The company is taking adequate steps to ensure re-functioning of the plant at the earliest, it said.

Shalimar Paints net profit rose 95.97% to Rs 2.43 crore on 0.11% increase in total income to Rs 103.15 crore in Q2 September 2016 over Q2 September 2015.

Shalimar Paints is Indias iconic paint-maker. Established in 1902, the countrys first paint company is a pioneer in the field of paints and coatings.

Powered by Capital Market - Live News

Volumes jump at Thomas Cook (India) counter
Nov 21,2016

Thomas Cook (India) clocked volume of 7.17 lakh shares by 14:23 IST on BSE, a 41.84-times surge over two-week average daily volume of 17,000 shares. The stock lost 2.15% at Rs 189.15.

Shriram City Union Finance notched up volume of 51,000 shares, a 7.24-fold surge over two-week average daily volume of 7,000 shares. The stock was up 1.82% at Rs 1,840.

Upper Ganges Sugar & Industries saw volume of 5.41 lakh shares, a 5.94-fold surge over two-week average daily volume of 91,000 shares. The stock spurted 12.81% at Rs 294.50.

Glenmark Pharmaceuticals clocked volume of 2.58 lakh shares, a 4.69-fold surge over two-week average daily volume of 55,000 shares. The stock lost 1.72% at Rs 883.

Dwarikesh Sugar Industries saw volume of 2.27 lakh shares, a 4.46-fold rise over two-week average daily volume of 51,000 shares. The stock rose 3.93% at Rs 265.80.

Powered by Capital Market - Live News